HeMemics Biotechnologies
PrivateLast Round
VC Round
Mar 19, 2025
Total Funding Raised
$5.26M
Company Overview
HeMemics Biotechnologies operates in Healthcare & Life Sciences and is based in Gaithersburg, Maryland. Its latest recorded funding round was a VC Round in March 2025.
HeMemics Biotechnologies is a biotechnology company that develops a handheld, graphene-based biosensor platform for simultaneous testing of antibodies, antigens, and molecular targets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Sensors, Defense Tech, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HeMemics Biotechnologies Comparables
Compare HeMemics Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IdentifySensors Biologics | 83% | |
| Sapphiros | 81% | |
| GRIP Molecular Technologies | 78% |
For institutional investors. Book with your work email.
HeMemics Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 19, 2025 | ||||
| Grant | Jun 7, 2023 | ||||
| Seed | May 25, 2023 | ||||
| Seed | Dec 11, 2019 | ||||
| Grant | Jan 31, 2008 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
HeMemics Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| TEDCO | Grant, Seed, VC Round |
| Inova Strategic Investments | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 19, 2025
$250K round led by TEDCO
- May 25, 2023
$2M round led by TEDCO.
For institutional investors. Book with your work email.
HeMemics Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HeMemics Biotechnologies's valuation, stock price, and market status.
Is HeMemics Biotechnologies a public or private company?
HeMemics Biotechnologies is a private company.
What is the current stock price of HeMemics Biotechnologies?
HeMemics Biotechnologies is a private company, so its shares have no public market price. Caplight tracks HeMemics Biotechnologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HeMemics Biotechnologies worth (valuation)?
Valuation information for HeMemics Biotechnologies is not publicly available.
Can I buy HeMemics Biotechnologies stock?
HeMemics Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HeMemics Biotechnologies's last funding round?
HeMemics Biotechnologies's most recent funding round was VC Round on March 19, 2025.
Who are the main investors in HeMemics Biotechnologies?
Key investors in HeMemics Biotechnologies include TEDCO.
Will HeMemics Biotechnologies IPO soon?
No public IPO plans have been announced for HeMemics Biotechnologies.
How can I track HeMemics Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades in HeMemics Biotechnologies's shares on secondary markets.